The effects of denosumab and alendronate on glucocorticoid-induced osteoporosis in patients with glomerular disease: A randomized, controlled trial

INTRODUCTION: The clinical utility of denosumab for the treatment of glucocorticoid-induced osteoporosis (GIOP) has yet to be established. This study aimed to compare the effects of denosumab on bone mineral density (BMD) and bone turnover markers to those of alendronate in patients with GIOP. METHO...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:PLoS One
Autori principali: Iseri, Ken, Iyoda, Masayuki, Watanabe, Makoto, Matsumoto, Kei, Sanada, Daisuke, Inoue, Takashi, Tachibana, Shohei, Shibata, Takanori
Natura: Artigo
Lingua:Inglês
Pubblicazione: Public Library of Science 2018
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5854344/
https://ncbi.nlm.nih.gov/pubmed/29543887
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0193846
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi